Skip to main content

Advertisement

SpringerLink
Log in

Human choriogonadotropin prior to controlled ovarian stimulation and in vitro fertilization improves implantation, and pregnancy rates

  • ASSISTED REPRODUCTION
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

Our purpose was to retrospectively compare controlled ovarian stimulation(COH) in IVF cycles with administration of hCG on the day of menses (D1-hCG) with women not receiving hCG at day 1 of menses (Control).

Methods

Data on maternal age, endocrine profile, amount of rFSH required, embryo characteristics, implantation and pregnancy rates were recorded for comparison between D1-hCG (n = 36) and Control (n = 64).

Results

Dose of rFSH required to accomplish COH was significantly lower in D1-hCG. Following ICSI, more top-quality embryos were available for transfer per patient in the D1-hCG and biochemical pregnancy rates per transfer were significantly higher in the D1-hCG. Significantly higher implantation and on-going pregnancy rates per embryo transfer were observed in D1-hCG (64%) compared to Control (41%).

Conclusions

Administration of D1-hCG prior to COH reduces rFSH use and enhances oocyte developmental competence to obtain top quality embryos, and improves implantation and on-going pregnancy rates. At present it is not clear if the benefit is related to producing an embryo that more likely to implant or a more receptive uterus, or merely fortuitous and related to the relatively small power of the study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gourgeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996;17:121–55.

    Google Scholar 

  2. Mais V, Kazer RR, Cetel NS, Rivier J, Vale W, Yen SS. The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin- releasing hormone antagonist as a probe. J Clin End Metab. 1986;62:1250–5.

    Article  CAS  Google Scholar 

  3. Ginther OJ, Beg MA, Gastal EL, Gastal MO, Baerwald AR, Pierson RA. Systemic concentrations of hormones during the development of follicular waves in mares and women: a comparative study. Reproduction. 2005;130:379–88. doi:10.1530/rep. 1.00757.

    Article  PubMed  CAS  Google Scholar 

  4. Eppig JJ. Oocyte control of ovarian follicular development and function in mammals. Reproduction. 2001;122:829–38. doi:10.1530/rep.0.1220829.

    Article  PubMed  CAS  Google Scholar 

  5. Albertini DF, Combelles CM, Benecchi E, Carabatsos MJ. Cellular basis for paracrine regulation of ovarian follicle development. Reproduction. 2001;121:647–53. doi:10.1530/rep.0.1210647.

    Article  PubMed  CAS  Google Scholar 

  6. Eppig JJ, Wigglesworth K, Pendola FL. The mammalian oocyte orchestrates the rate of ovarian follicular development. Proc Natl Acad Sci USA. 2002;99:2890–4. doi:10.1073/pnas.052658699.

    Article  PubMed  CAS  Google Scholar 

  7. Maruo T, Ladines-Llave CA, Samoto T, Matsuo H, Manalo A, Ito H, et al. Expression of Epidermal Growth Factor and Its Receptor in the Human Ovary during Follicular Growth and Regression. Endocrinology. 1993;132:924–31. doi:10.1210/en.132.2.924.

    Article  PubMed  CAS  Google Scholar 

  8. Webb R, Garnsworthy PC, Gong JG, Armstrong DG. Control of follicular growth: local interactions and nutritional influences. J Anim Sci. 2004;82(E. Suppl):E63–74.

    PubMed  Google Scholar 

  9. Balasch J, Miro F, Burzaco I, Casamitjana R, Civico S, Ballesca JL, et al. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone. Hum Reprod. 1995;10:1678–83.

    PubMed  CAS  Google Scholar 

  10. Filicori M, Fazleabas AT, Huhtaniemi I, Licht P, Rao C, Tesarik J, et al. Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility. Fertil Steril. 2005;84:275–84. doi:10.1016/j.fertnstert.2005.02.033.

    Article  PubMed  CAS  Google Scholar 

  11. Törnell J, Bergh C, Selleskog U, Hillensjö T. Effect of recombinant human gonadotrophins on oocyte meiosis and steroidogenesis in isolated pre-ovulatory rat follicles. Mol Hum Reprod. 1995;1:219–22. doi:10.1093/molehr/1.4.219.

    Article  Google Scholar 

  12. Burgués S. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain. Hum Reprod. 2001;16:2525–32. doi:10.1093/humrep/16.12.2525.

    Article  PubMed  Google Scholar 

  13. Greisen S, Ledet T, Ovesen P. Effects of androstenedione, insulin and luteinizing hormone on steroidogenesis in human granulosa luteal cells. Hum Reprod. 2001;16:2061–5. doi:10.1093/humrep/16.10.2061.

    Article  PubMed  CAS  Google Scholar 

  14. Thiruppathi P, Shatavi S, Dias JA, Radwanska E, Luborsky JL. Gonadotrophin receptor expression on human granulosa cells of low and normal responders to FSH. Mol Hum Reprod. 2001;7:697–704. doi:10.1093/molehr/7.8.697.

    Article  PubMed  CAS  Google Scholar 

  15. Schipper I, Hop WC, Fauser BC. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects folli. J Clin Endocrinol Metab. 1998;83:1292–8. doi:10.1210/jc.83.4.1292.

    Article  PubMed  CAS  Google Scholar 

  16. Cédrin-Durnerin I, Grange-Dujardin D, Laffy A, Parneix I, Massin N, Galey J, et al. Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study. Hum Reprod. 2004;19:1979–84. doi:10.1093/humrep/deh369.

    Article  PubMed  CAS  Google Scholar 

  17. De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolino A, et al. On behalf of the Italian collaborative group on: recombinant human luteinizing hormone recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod. 2005;20:390–6. doi:10.1093/humrep/deh625.

    Article  PubMed  CAS  Google Scholar 

  18. Andersen AN, Devroey P. Arce JC for the MERIT Group: Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod. 2006;21:3217–27. doi:10.1093/humrep/del284.

    Article  PubMed  CAS  Google Scholar 

  19. Tarlatzis B, Tavmergen E, Szamatowicz M, Barash A, Amit A, Levitas E, et al. The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study. Hum Reprod. 2006;21:90–4. doi:10.1093/humrep/dei293.

    Article  PubMed  CAS  Google Scholar 

  20. Kolibianakis EM, Kalogeropoulou L, Griesinger G, Papanikolaou EG, Papadimas J, Bontis J, et al. Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis. Hum Reprod Update. 2007;13:445–52. doi:10.1093/humupd/dmm008.

    Article  PubMed  CAS  Google Scholar 

  21. Serafini P, Yadid I, Motta EL, Alegretti JR, Fioravanti J, Coslovsky M. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial. Fertil Steril. 2006;86:830–8. doi:10.1016/j.fertnstert.2006.02.110.

    Article  PubMed  CAS  Google Scholar 

  22. Filicori M, Cognigni GE, Samara A, Melappioni S, Perri T, Cantelli B, et al. The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction. Hum Reprod Update. 2002;8:543–57. doi:10.1093/humupd/8.6.543.

    Article  PubMed  CAS  Google Scholar 

  23. Filicori M, Cognigni GE, Gamberini E, Parmegiani L, Troilo E, Roset B. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertil Steril. 2005;84:394–401. doi:10.1016/j.fertnstert.2005.02.036.

    Article  PubMed  CAS  Google Scholar 

  24. Hugues JN, Soussis J, Calderon I, Balasch J, Anderson RA, Romeu A. Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study. Hum Reprod. 2005;20:629–35. doi:10.1093/humrep/deh682.

    Article  PubMed  CAS  Google Scholar 

  25. Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992;340:17–8. doi:10.1016/0140-6736(92)92425-F.

    Article  PubMed  CAS  Google Scholar 

  26. Yadid I, Coslowsky M, Ribeiro CV, Motta ELA, Serafini PC. Follicle recruitment for IVF following administration of choriogonadotropin alpha (rec-hCG) on the day of spontaneous menstruation. Hum Reprod. 2005;20(Suppl. 1):i122–8.

    Google Scholar 

  27. Ji I, Lee C, Song Y, Conn M, Ji T. Cis- and Trans-activation of hormone receptors: the LH receptor. Mol Endocrinol. 2002;16:1299–308. doi:10.1210/me.16.6.1299.

    Article  PubMed  CAS  Google Scholar 

  28. Zelinski-Wooten MB, Hutchison JS, Trinchard-Lugan I, Hess DL, Wolf DP, Stouffer RL. Initiation of periovulatory events in gonadotrophin-stimulated macaques with varying doses of recombinant human chorionic gonadotrophin. Hum Reprod. 1997;12:1877–85. doi:10.1093/humrep/12.9.1877.

    Article  PubMed  CAS  Google Scholar 

  29. Young J, Rey R, Schaison G, Chanson P. Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Mullerian hormone secretion in humans. Mol Cell Endocrinol. 2003;211:51–4. doi:10.1016/j.mce.2003.09.020.

    Article  PubMed  CAS  Google Scholar 

  30. Coomarasamy A, Afnan M, Cheema D, van der Veen F, Bossuyt PMM, van Wely M. Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis. Hum Reprod. 2008;23:310–5. doi:10.1093/humrep/dem305.

    Article  PubMed  CAS  Google Scholar 

  31. Baerwald AR, Adams GP, Pierson RA. Characterization of ovarian follicular wave dynamics in women. Biol Reprod. 2003;69:1023–31. doi:10.1095/biolreprod.103.017772.

    Article  PubMed  CAS  Google Scholar 

  32. Ginther OJ, Gastal EL, Gastal MO, Bergfelt DR, Baerwald AR, Pierson RA. Comparative study of the dynamics of follicular waves in mares and women. Biol Reprod. 2004;7:1195–201. doi:10.1095/biolreprod.104.031054.

    Article  CAS  Google Scholar 

  33. Orvieto R, Meltzer S, Rabinson J, Zohav E, Anteby EY, Nahum R. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity. Fertil Steril. 2008;90:1294–6. doi:10.1016/j.fertnstert.2007.10.022.

    Article  PubMed  CAS  Google Scholar 

  34. Check JH, Summers-Chase D, Yuan W, Horwath D, Wilson C. Effect of embryo quality on pregnancy outcome following single embryo transfer in women with a diminished egg reserve. Fertil Steril. 2007;87:749–56. doi:10.1016/j.fertnstert.2006.11.001.

    Article  PubMed  Google Scholar 

  35. Louvet JP, Harman SM, Ross GT. Effects of human chorionic gonadotropin, human interstitial cell stimulating hormone and human follicle-stimulating hormone on ovarian weights in estrogen-primed hypophysectomized immature female rats. Endocrinology. 1975;96:1179–86.

    Article  PubMed  CAS  Google Scholar 

  36. Filicori M, Flamigni C, Cognigni GE, Falbo A, Arnone R, Capelli M, et al. Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis. Fertil Steril. 1996;65:387–93.

    PubMed  CAS  Google Scholar 

  37. Mason HD, Cwyfan-Hughes SC, Heinrich G, Franks S, Holly JMP. Insulin-Like Growth Factor (IGF) I and II, IGF-Binding Proteins, and IGF-Binding Protein Proteases Are Produced by Theta and Stroma of Normal and Polycystic Human Ovaries. Clin Endocrinol Metab. 1996;81:276–84. doi:10.1210/jc.81.1.276.

    Article  CAS  Google Scholar 

  38. Gómez E, de los Santos MJ, Ruiz A, Tarín JJ, Remohí J, Pellicer A. Effects of epidermal growth factor in the final stages of nuclear and cytoplasmic oocyte maturation in humans. Hum Reprod. 1993;8:691–4.

    PubMed  Google Scholar 

  39. Artini PG, Battaglia C, D’ Ambrogio G, Barreca A, Droghini F, Volpe A, et al. Relationship between human oocyte maturity, fertilization and follicular fluid growth factors. Hum Reprod. 1994;9:902–6.

    PubMed  CAS  Google Scholar 

  40. Kawamura K, Kawamura N, Mulders SM, Sollewijn G, Hsueh AJ. Ovarian brain-derived neurotrophic factor (BDNF) promotes the development of oocytes into preimplantation embryos. Proc Natl Acad Sci USA. 2005;102:9206–11. doi:10.1073/pnas.0502442102.

    Article  PubMed  CAS  Google Scholar 

  41. Paredes A, Romero C, Dissen GA, DeChiara TM, Reichardt L, Cornea A, et al. TrkB receptors are required for follicular growth and oocyte survival in the mammalian ovary. Dev Biol. 2004;267:430–49. doi:10.1016/j.ydbio.2003.12.001.

    Article  PubMed  CAS  Google Scholar 

  42. Spears N, Molinek MD, Robinson LL, Fulton N, Cameron H, Shimoda K, et al. The role of neurotrophin receptors in female germ-cell survival in mouse and human. Development. 2003;130:5481–91. doi:10.1242/dev.00707.

    Article  PubMed  CAS  Google Scholar 

  43. Freidman S, Gurevich M, Shemesh M. Bovine cyclic endometrium contains high-affinity luteinizing hormone/human chorionic gonadotropin binding sites. Biol Reprod. 1995;52:1020–6. doi:10.1095/biolreprod52.5.1020.

    Article  PubMed  CAS  Google Scholar 

  44. Srisuparp S, Strakova Z, Brudney A, Mukherjee S, Reierstad S, Hunzicker-Dunn M, et al. Signal Transduction Pathways Activated by Chorionic Gonadotropin in the Primate Endometrial Epithelial Cells. Biol Reprod. 2003;68:457–64. doi:10.1095/biolreprod.102.007625.

    Article  PubMed  CAS  Google Scholar 

  45. Fields MJ, Shemesh M. Extragonadal Luteinizing Hormone Receptors in the Reproductive Tract of Domestic Animals. Biol Reprod. 2004;71:1412–8. doi:10.1095/biolreprod.104.027201.

    Article  PubMed  CAS  Google Scholar 

  46. Licht P, Fluhr H, Neuwinger J, Wallwiener D, Wildt L. Is human chorionic gonadotropin directly involved in the regulation of human implantation? Mol Cell Endocrinol. 2007;269:85–92. doi:10.1016/j.mce.2006.09.016.

    Article  PubMed  CAS  Google Scholar 

  47. Licht P, von Wolff M, Berkholz A, Wildt L. Evidence for cycle-dependent expression of full-length human chorionic gonadotropin/luteinizing hormone receptor mRNA in human endometrium and decidua. Fertil Steril. 2003;79(Suppl .1):718–23.

    Article  PubMed  Google Scholar 

  48. Cameo P, Szmidt M, Strakova Z, Mavrogianis P, Sharpe-Timms KL, Fazleabas AT. Decidualization regulates the expression of the endometrial chorionic gonadotropin receptor in the primate. Biol Reprod. 2006;75:681–9. doi:10.1095/biolreprod.106.051805.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to express appreciation to Claudia Vieira, Beto Jalegretti, Joyce Fioravanti, and Lia Rossi for technical and editorial input and comments. Additionally, the authors thank Dr. Carrie Cosola-Smith and Jeni Chapman for editorial comments.

Author information

Authors and Affiliations

  1. Huntington Center for Reproductive Medicine of Brazil, Rua Joana Angelica, 228, Ipanema, Rio de Janeiro, 22420-030, Brazil

    Eduardo L. Motta, Paulo C. Serafini, Marcio Coslovsky, Andre M. Rocha & Isaac Yadid

  2. Huntington Medicina Reprodutiva, Av. República do Líbano, 529-São Paulo, 04501-000, SP, Brazil

    Eduardo L. Motta, Paulo C. Serafini & Andre M. Rocha

  3. Departamento de Ginecologia, Faculdade de Medicina, Universidade de São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255 São Paulo, SP, 05403-000, Brazil

    Paulo C. Serafini

  4. Departamento de Ginecologia, Universidade Federal de São Paulo, Rua Botucatu, 740 São Paulo, SP, 04023-900, Brazil

    Eduardo L. Motta

  5. Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA

    Gary D. Smith

  6. Department of Urology, University of Michigan, Ann Arbor, MI, USA

    Gary D. Smith

  7. Department of Physiology, University of Michigan, Ann Arbor, MI, USA

    Gary D. Smith

  8. Reproductive Science Program, University of Michigan, Ann Arbor, MI, USA

    Gary D. Smith

  9. Genesis Genetics Brasil, São Paulo, Brazil

    Pericles Hassun

Authors
  1. Eduardo L. Motta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gary D. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paulo C. Serafini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marcio Coslovsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pericles Hassun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Andre M. Rocha
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Isaac Yadid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Isaac Yadid.

Additional information

Capsule Administration of hCG on the start of controlled ovarian hyperstimulation (D1-hCG) significantly increases implantation and on-going pregnancy rates

Rights and permissions

Reprints and permissions

About this article

Cite this article

Motta, E.L., Smith, G.D., Serafini, P.C. et al. Human choriogonadotropin prior to controlled ovarian stimulation and in vitro fertilization improves implantation, and pregnancy rates. J Assist Reprod Genet 26, 305–311 (2009). https://doi.org/10.1007/s10815-009-9322-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-009-9322-x

Keywords

Search

Navigation